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Brain recovery after cardiac arrest (CA) was assessed in cats using arterial spin tagging perfusion-weighted imaging (PWI),
diffusion-weighted imaging (DWI), and 1H-spectroscopy (1H-MRS). Cerebral reperfusion and metabolic recovery was monitored in
the cortex and in basal ganglia for 6 h after cardiopulmonary resuscitation (CPR). Furthermore, the effects of an hypertonic/
hyperoncotic solution (7.5% NaCl/6% hydroxyl ethyl starch, HES) and a tissue-type plasminogen activator (TPA), applied during
CPR, were assessed on brain recovery. CA and CPR were carried out in the MR scanner by remote control. CA for 15/20 min was
induced by electrical fibrillation of the heart, followed by CPR using a pneumatic vest. PWI after successful CPR revealed initial
cerebral hyperperfusion followed by delayed hypoperfusion. Initial cerebral recirculation was improved after osmotic treatment.
Osmotic and thrombolytic therapy were ineffective in ameliorating delayed hypoperfusion. Calculation of the apparent diffusion
coefficient (ADC) from DWI demonstrated complete recovery of ion and water homeostasis in all animals. 1H-MRS measurements
of lactate suggested an extended preservation of post-ischaemic anaerobic metabolism after TPA treatment. The combination of
noninvasive MR techniques is a powerful tool for the evaluation of therapeutical strategies on circulatory and metabolic cerebral
recovery after experimental cerebral ischaemia.
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Resumo
Avaliou-se a recuperac¸a˜o cerebral de gatos apo´s paragem cardı´aca (CA)..... com imagens de avaliac¸a˜o da perfusa˜o (PWI) e
imagens de avaliac¸a˜o da difusa˜o (DWI) em espectrofotometria 1H (1H-MRS). A perfusa˜o cerebral foi monitorizada no co´rtex e nos
gaˆnglios da base durante seis horas a seguir a` reanimac¸a˜o cardio-pulmonar (CPR). Avaliaram-se ainda os efeitos de uma soluc¸a˜o
hiperosmo´tica e hiperonco´tica (NaCl hiperto´nico 7.5% / hidroxi etil starch HES a 6%) e um activador tecidular do plasminoge´neo
(TPA), administrado durante a reanimac¸a˜o e avaliado na fase de recuperac¸a˜o. A CA e a RCP foram executadas, por controlo
remoto, no scanner da ressonaˆncia magne´tica. A CA foi induzida, por descarga ele´ctrica, durante 15/20 min, sendo a reanimac¸a˜o
feita por colete pneuma´tico. A PWI depois da CPR com sucesso evidenciou uma hiperperfusa˜o cerebral inicial seguida de
hipoperfusa˜o. A recirculac¸a˜o cerebral inicial melhorou com a administrac¸a˜o da soluc¸a˜o osmo´tica. O tratamento osmo´tico e
Abbreviations: ADC, apparent diffusion coefficient of water; ALS, advanced life support; CA, cardiac arrest; CBF, cerebral blood flow; CPR,
cardiopulmonary resuscitation; Cr/PCr, creatine/phosphocreatine; DWI, diffusion-weighted imaging; HHS, hypertonic/hyperoncotic solution; 1H-
MRS, 1H-proton spectroscopy; PWI, perfusion-weighted imaging; ROSC, return of spontaneous circulation; TPA, tissue-type plasminogen
activator.
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trombolı´tico na˜o preveniram a hipoperfusa˜o tardia. O ca´lculo da difusa˜o aparente (ADC) a partir do DWI demonstra uma
recuperac¸a˜o completa, em todos os animais, da homeostasia de io˜es e a´gua. A medic¸a˜o do lactato por 1H-MRS sugere uma
persisteˆncia prolongada do metabolismo anaero´bio depois do tratamento com TPA. A combinac¸a˜o das te´cnicas de RM e´ um
instrumento poderoso para avaliac¸a˜o das estrate´gias terapeˆuticas na recuperac¸a˜o da circulac¸a˜o e metabolismo cerebrais cerebrais no
perı´odo po´s isquemia cerebral experimental.
# 2003 Elsevier Ireland Ltd. All rights reserved.
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hiperto´nicas e trombo´lise
Resumen
La recuperacio´n cerebral despue´s de un paro cardı´aco (CA) fue evaluada en gatos usando imagenologı´a de medicio´n de perfusio´n
arterial (PWI) con marcadores de spin, imagenologı´a de medicio´n de difusio´n (DWI), y espectroscopia-1H (1H-MRS). La
reperfusio´n cerebral y recuperacio´n metabo´lica fue monitoreada en la corteza y en los ganglios basales por 6 horas despue´s de
reanimacio´n cardiopulmonar (CPR). Se evaluo´ el efecto sobre la recuperacio´n cerebral de una solucio´n hiperto´nica / hiperonco´tica
(7.5%NaCl / 6%hidroxi ethyl starch, HES) y un activador de plasmino´geno tisular (TPA), aplicados durante la CPR. El paro
cardı´aco y la reanimacio´n fueron llevados a cabo en el tomo´grafo de resonancia magne´tica (MR) por control remoto. Se indujo paro
cardı´aco por fibrilacio´n ele´ctrica del corazo´n, se mantuvo por 15/20 minutos, seguido de CPR usando un chaleco neuma´tico. PWI
despue´s de CPR exitosa revelo´ hiperperfusio´n cerebral inicial seguida de hipoperfusio´n tardı´a. La recirculacio´n inicial mejoro´
despue´s del tratamiento osmo´tico. La terapia osmo´tica y trombolı´tica fueron inefectivas en mejorar la hipoperfusio´n tardı´a. El
calculo del coeficiente de difusio´n aparente (ADC) por medio de DWI demostro´ una recuperacio´n completa de de la homeostasis de
iones y de agua en los animales. Las mediciones de lactato con 1H-MRS sugieren una extensa preservacio´n del metabolismo
anaerobio post isque´mico despue´s del tratamiento con TPA. La combinacio´n de te´cnicas no invasivas de MR es una herramienta
poderosa para la evaluacio´n de estrategias terape´uticas en recuperacio´n circulatoria y metabo´lica cerebral despue´s de isquemia
cerebral experimental.
# 2003 Elsevier Ireland Ltd. All rights reserved.
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Successful resuscitation from cardiac arrest frequently
is complicated by severe brain injury. About 50% of
short-term survivors die in permanent coma, and 10/
30% of long-term survivors suffer permanent brain
damage [1]. The restoration of the functional and the
biochemical integrity of the brain after a period of
prolonged cardiac arrest (CA) may be severely compro-
mised by cerebral recirculation disturbances such as the
no-reflow phenomenon [2] and the delayed hypoperfu-
sion syndrome [3]. No-reflow is characterized by in-
complete post-ischaemic microvascular filling [2],
exacerbated by increasing duration of ischaemia [4].
The delayed hypoperfusion syndrome develops after a
transient phase of reactive hyperaemia and is associated
with a disturbed coupling between blood flow and
metabolism [5]. After short periods of cerebral ischae-
mia post-ischaemic hypoperfusion is present already
after 10 min of recirculation [6], and after prolonged
global ischaemia the disturbances may last several days
[7].
Using magnetic resonance (MR) imaging and spectro-
scopy techniques noninvasive physiological monitoring
of cerebral blood flow (CBF), metabolic integrity, and
brain water homeostasis can be accomplished in experi-
mental animal models of cerebral ischaemia. One of the
great advantages of in vivo MR investigations of
cerebral ischaemia models is the ability to perform
longitudinal studies in which the relationship between
the time courses of post-ischaemic CBF and metabolic
recovery can be evaluated in various brain structures. In
the present study, perfusion-weighted imaging (PWI)
was performed, for the first time, in a feline model of
prolonged CA and cardiopulmonary resuscitation
(CPR) by an ultrafast version of the arterial spin tagging
method based on snapshot FLASH imaging. This
method allows recording of fast cerebral perfusion
changes in rats [8,9], and has not been employed before
to describe the post-ischaemic CBF variations in experi-
mental models of global cerebral ischaemia. Diffusion-
weighted imaging (DWI) was used to calculate the
apparent diffusion coefficient of water (ADC). The
ADC is sensitive to alterations of intracellular water
homeostasis and cell volume, and is able to differentiate
between reversible and irreversible brain injury [10/13].
Finally, localized 1H-spectroscopy (1H-MRS) was used
to monitor the lactate changes in the brain as a measure
of anaerobic metabolic activity [14,15].
Brain resuscitation and neurological recovery after
prolonged CA requires successful treatment of cerebral
recirculation disturbances. A close relationship between
prevention of no-reflow [16,17] treatment of delayed
hypoperfusion [18,19] and the functional cerebral re-
covery process has been established. In earlier investiga-
tions of our laboratory it was demonstrated that the
combination of standard advanced life support [20] with
application of either a hypertonic/hyperoncotic solution
(7.5% NaCl in 6% hydroxy ethyl starch) or a tissue-type
plasminogen-activator (TPA) significantly reduced cere-
bral no-reflow [21,22]. The effects of these newer
therapeutical approaches on post-ischaemic cerebral
reperfusion characteristics and, in particular, the de-
layed hypoperfusion syndrome have not been evaluated
to date.
In this paper we describe an investigation in which an
array of MR techniques including PWI, DWI, and 1H-
MRS has been employed to evaluate post-ischaemic
cerebral reperfusion and metabolic recovery in cats
during the first 6 h after resuscitation from prolonged
CA. Furthermore, the effects of osmotic or thrombolytic
therapy, both initiated with the onset of CPR, on the
MR variables were assessed. Induction of CA and CPR
were remotely performed in the MR scanner allowing us
to perform repeated measurements throughout the
recirculation period beginning with the return of spon-
taneous circulation.
2. Material and methods
2.1. General preparation and recording of physiological
variables
All experiments were carried out in accordance with
the German legislation on animal care, and approved by
the local authorities. In twelve adult male mongrel cats
(2.9/3.4 kg) anaesthesia was initiated by inhalation of
halothane in N2O/O2 (7/3). After tracheal intubation the
animals were immobilized (pancuronium bromide 0.12
mg/kg/h) and mechanically ventilated (Harvard Appa-
ratus, South Natick, MA). Tidal volume and ventilation
rate were adjusted to maintain an end-exspiratory
carbon dioxide pressure (EtCO2) of 35/40 mmHg. A
femoral artery and vein were cannulated with 3F/5F
catheters for measurement of arterial blood pressure,
blood sampling, and for drug and fluid administration.
Via the contralateral femoral vein a 3F pacing catheter
(Vygon, Aachen, Germany) was placed into the right
atrium for intracardial ECG recording. Rectal tempera-
ture was measured with a thermistor probe and kept
constant at 37 8C using a feed-back controlled warm
water jacket. After completion of surgical preparations,
the animals were turned to the prone position and two
flat, flexible copper defibrillator electrodes were at-
tached to the chest. Then, an inflatable vest developed
for extrathoracal cardiac compression was placed
around the thorax and connected to a compressor.
During CPR the vest was inflated with pressurized
nitrogen at a rate of 80/120/min until spontaneous
cardiac function returned. Finally, the animals were
fixed in a non-magnetic headholder and positioned in
the magnet of the MR scanner.
The MABP was measured continuously using high-
fidelity pressure transducers (Braun Medical AG, Mel-
sungen, Germany), and EtCO2 was monitored with a
medical gas analyzer LB2 (Sensor Medica Corp.,
Anaheim, CA, USA). Data were recorded on an eight-
channel polygraph (5525 C Dynograph, Beckman
Instruments, IL) and processed on a PC running the
DasyLab data acquisition software (Datalog, Mo¨nchen-
gladbach, Germany). Arterial blood samples were taken
at defined time points for analysis of blood gases and
electrolytes (blood gas system 288, Bayer Diagnostics,
Fernwald, Germany), and glucose (glucose analyzer 2,
Beckman Instr., Fullerton, CA).
2.2. Cardiac arrest and resuscitation protocol
The animals were randomly assigned to one of the
following resuscitation protocols: (1) standard CPR
according to the AHA guidelines [20]; (2) CPR in
combination with osmotic therapy by i.v. infusion of a
hypertonic/hyperoncotic solution (HHS); (3) CPR in
combination with thrombolytic therapy by i.v. injection
of a tissue-type plasminogen-activator (TPA; Actilyse†,
Boehringer-Ingelheim, Ingelheim, Germany) and he-
parin.
CA and CPR were carried out in the magnet of the
MR scanner by remote control. CA was induced by
electrical fibrillation for 1 min (AC 30 V, 5 mA, 50 Hz)
through the pacing catheter. During CA, mechanical
ventilation, anaesthesia, and infusions were interrupted
and the heating system was switched off. CPR was
started after 15/20 min CA with i.v. injection of 0.2 mg/
kg adrenaline (epinephrine) followed by extrathoracic
cardiac compression using the pneumatic vest. Artificial
ventilation was resumed with 100% O2 at a rate 50%
above control and the heating system was restarted. At
this time, either osmotic or thrombolytic therapy was
initiated. For osmotic therapy, 2 ml/kg HHS were
infused over 10 min, and thrombolytic therapy was
started with a bolus injection of 1 mg/kg TPA and 100
IE/kg heparin followed by the infusion of 1 mg/kg TPA
over 30 min. Animals of the standard CPR group
received 2 ml/kg/10 min Ringer’s solution. After 3 min
of chest compression, the first defibrillation (20 J) was
carried out using the external defibrillator electrodes. If
the defibrillation failed to induce return of spontaneous
circulation (ROSC), an additional dose of adrenaline
was injected and the heart massage was continued for
another 3 min until the next defibrillation was per-
formed. After ROSC, 1 mEq/kg/10 min sodium bicar-
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bonate (NaHCO3) were infused, and Ringer’s solution
and pancuronium infusions were resumed.
2.3. NMR measurements
NMR measurements were performed on a 47/30
Bruker BIOSPEC MSL-X11 system (Bruker, Ettlingen,
Germany) using a 4.7 T 30 cm inner diameter horizontal
bore magnet equipped with actively shielded gradient
coils (100 mT/m; gradient rise time 5/250 ms). A 12-cm
diameter Helmholtz coil attached to the nonmagnetic
headholder was used for RF transmission, and a 4.0-cm
diameter surface coil with inductive coupling was placed
over the skull of the animals for signal reception. The
two coils were decoupled from each other, the trans-
mitter coil actively and the surface coil passively. A third
coil with a 4.5-cm diameter was positioned below the
neck of the animals for arterial spin tagging. Multislice
sagittal pilot scans (TR/1000 ms, TE/12 ms) were
acquired for the selection of five coronal slices at
Horsley-Clark coordinates A20-P10. The slice thickness
was 3 mm and the interslice gap was 4 mm.
PWI and DWI were repeatedly performed before and
up to 6 h after CA, 1H-MRS also during CA. 1H-
spectroscopic measurements during CA were performed
at defined time points, in the cortex 5 min and in the
basal ganglia 10 min after the onset of CA.
PWI was performed using the ultrafast arterial spin
tagging technique as previously described in detail [8].
The PWI sequence consisted of two similar image
acquisition phases separated by a recovery period.
Each phase comprised a magnetization preparation
step and was followed by snapshot FLASH imaging.
During the first phase (inversion imaging), magnetiza-
tion of the blood flowing cranially through the neck was
inverted adiabatically using a field sweep through the
combination of a magnetic field gradient (1 G/m applied
in the z-direction) and an off-resonance B1 field (50 mG)
chosen to excite a defined slice through the neck. During
the second phase (control imaging), the magnetic field
gradient was reversed so that inflowing spins were left
undisturbed. The two images exhibited the same signal
loss due to magnetization transfer effects but differed in
the magnetization of the inflowing blood [23]. Perfusion-
weighted images were obtained by subtracting inversion
and control images from each other. Snapshot FLASH
acquisitions used centric phase encoding starting at zero
phase gradient with a TR of 7.4 ms and TE of 3.9 ms. RF
flip angle a was set to 188. The field of view was 8 cm
with a slice thickness of 5 mm, the image matrix was
128/64.
DWI was performed using a multislice Stejskal-
Tanner pulsed gradient spin-echo sequence (TE/35.2
ms, TR/2325 ms). Five slices with a thickness of 3 mm
and an interslice distance of 4 mm were obtained. The
field of view was 8 cm with an image matrix of 128/64
pixels. For quantitative determination of the ADC,
images were recorded with two different diffusion-
weighting factors b (b/20 and 1500 s/mm2). To
improve temporal resolution, unweighted spin echoes
(b/0 s/mm2) were recorded intermittently and com-
bined with the subsequently recorded weighted spin
echoes (b/1500 s/mm2). Data postprocessing included
correction for image-specific background noise [24].
Calculation of ADC was performed using the mono-
exponential intravoxel incoherent motion (IVIM) model
[25]. Quantitative ADC images were compiled using
IDL (Research Systems Inc., Boulder, CO) on a Silicon
Graphics workstation (Silicon Graphics Inc., Boulder,
CO). Regions of interest (ROI) were selected in the
parietal cortex and in the area of the basal ganglia and
averaged for the calculation of the mean ADC on a
MacIntosh PC equipped with the image processing
software IMAGE (National Institutes of Health,
Bethesda, MD). The ROIs corresponded to voxels of
interest (VOI) in the same region selected for 1H-MRS.
MR-spectra were obtained from two 6/6/6 mm3
VOI’s using the PRESS spin-echo localization method
[15]. The acquisition time per spectrum was 2.5 min
(TE/20 ms, TR/2500 ms, 64 averages). The PRESS
localization was preceded by 3 CHESS water suppres-
sion cycles each using Gaussian shaped RF pulses of
25.6 ms duration. During the CHESS cycles crusher
gradient pulses of 45 mT/m in x and 90 mT/m in y
followed by an additional pulse of 90 mT/m in x were
applied. The spectra were processed on a Silicon
Graphics workstation using Paravision (Bruker, Ettlin-
gen, Germany). A 2 Hz Gaussian line broadening was
followed by Fourier transformation and zero- and first-
order phase correction. Selected spectral lines were
quantified by integration of the areas under the line
over a frequency range of 9/0.1 ppm. Lactate measure-
ments were taken at 1.3 ppm and related to the peak for
creatine/phosphocreatine (Cr/PCr) at 3.03 ppm in the
same spectrum in order to correct the data for fluctua-
tions of signal reception. Since the lactate signal at 1.3
ppm is colocalized with a lipid signal, the (lactate/
lipid)/(Cr/PCr)-ratio was calculated.
2.4. Bioluminescence and fluorescence imaging
Six hours after ROSC the animals were removed from
the magnet and the heads were frozen with liquid
nitrogen using the funnel freezing method [26]. After
removal from the skull the frozen brains were cut in the
cold room at /20 8C into four coronal slices, and
subsequently cut into 20 mm thin cryostat sections in the
same planes as the MR images. Adjacent sections were
processed for bioluminescence imaging of ATP, glucose,
and lactate [27/29], and for fluorescence imaging of
tissue pH [30]. The metabolite and the pH images were
digitized with a charge-coupled device (CCD) camera
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connected to a MacIntosh PC, and processed with the
image analysis system IMAGE. Bioluminescence images
were quantified by correlating optical densities with the
metabolite concentrations measured by standard enzy-
matic techniques in small tissue samples taken from
different parts of the cryostat block. Quantification of
pH images was performed using calibrated pH stan-
dards.
2.5. Statistical analysis
All data are expressed as means9/standard deviation
(S.D.). Changes of PWI and ADC measurements are
expressed in percent of the mean baseline values. Results
from 1H-MRS measurements of lactate, biolumines-
cence and fluorescence measurements, and physiological
variables are given in absolute numbers. Differences in
the time course of the various MR variables in the two
anatomical regions were analyzed for statistical signifi-
cance using a three-factorial analysis of variance (AN-
OVA) with a repeated measures factor and two between
group factors for treatment and duration of CA
(STATISTICA for Windows; StatSoft, Tulsa, OK).
For post-hoc analysis the LSD-test was employed.
Results from bioluminescence and fluorescence mea-
surements, and physiological variables were compared
using two-tailed Student’s t-test. Statistical significance
was assumed for pB/0.05.
3. Results
3.1. Survival rate and physiological variables
All animals were successfully resuscitated. The mean
duration of CPR was 10.19/1.1 min (range 8.8/11.3
min) for all animals, and ROSC was achieved in the
different treatment groups after almost identical periods
Fig. 1. Coronal arterial spin-tagging perfusion-weighted images and quantitative coronal ADC maps from a cat brain before and after 20 min of
cardiocirculatory arrest. During CPR the animal received an infusion of 2 ml/kg 7.2% NaCl/6% HES (HHS). Note the strong increase of the PWI-
signal intensity both in the cortex and in the area of the basal ganglia during the early reperfusion period (0.5 h recirculation) reflecting initial post-
ischaemic hyperperfusion, and the very low signal intensity at 4 h after ROSC reflecting delayed hypoperfusion. The DWI images demonstrate
reduced ADC during CA and complete normalization after 6 h recirculation.
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of ALS (standard: 9.99/1.3 min; HHS: 10.39/1.0 min;
TPA: 9.99/1.4 min).
Table 1 summarizes physiological variables after
resuscitation using the different therapeutical regimens.
In the first 40 min of recirculation high blood pressure
due to administration of adrenaline during CPR, a
decrease of the blood pH, an increase of partial blood
arterial oxygen pressure (PaO2) due to ventilation with a
FiO2 of 1.0, and post-ischaemic hyperglycaemia was
apparent in all animals. The time courses of post-
ischaemic MABP, blood pH, and PaO2were not affected
by the different protocols. Blood glucose was signifi-
cantly lower in TPA-treated animals already before
induction of CA, and the post-ischaemic glucose level
remained lower in these animals during the first 4 h of
reperfusion. However, during the last 2 h of the
observation period blood glucose returned to the control
range and at that point in time no longer differed from
the other groups.
3.2. Perfusion-weighted imaging
Perfusion-weighted images from a cat brain before
and after 20 min CA demonstrate the characteristic
post-ischaemic flow pattern with initial hyperperfusion
after 30 min recirculation followed by delayed hypo-
perfusion after 4 h recirculation (Fig. 1). Treatment
effects (HHS; TPA) were mainly detected in the early
reperfusion period. CPR in combination with HHS
induced a 3 to 3.5-fold increase of the PWI signal
intensity both in the cortex and in basal ganglia 20 min
after ROSC but only a twofold increase in the other two
groups (pB/0.05; Fig. 2). Initial hyperperfusion was
prolonged after HHS treatment, in these animals a
twofold increase was still present at 40 min after ROSC
Table 1
Physiological variables after standard CPR or resuscitation in combination with HHS or TPA
Prearrest Recirculation (min after ROSC)
20 40 60 120 180 240 300 360
MABP (mmHg)
Standard 1019/6 1619/25* 1479/16* 1079/3 989/5 809/7 799/6 759/5 759/3
HHS 969/5 1569/21$ 1409/10$ 1129/6 1009/4 919/5 879/6 909/5 909/7
TPA 879/5 1399/32§ 1259/9§ 1019/3 949/3 909/4 859/6 839/5 829/5
pH
Standard 7.359/0.02 7.119/0.09* 7.149/0.03* 7.309/0.06* 7.329/0.09 7.379/0.04 7.339/0.05 7.319/0.04 7.349/0.03
HHS 7.389/0.03 7.109/0.14$ 7.149/0.01$ 7.299/0.03 7.379/0.03 7.329/0.09 7.319/0.07 7.329/0.08 7.339/0.04
TPA 7.359/0.02 7.119/0.131§ 7.169/0.041§ 7.239/0.15 7.279/0.06 7.369/0.3 7.379/0.06 7.309/0.06 7.319/0.04
paO2 (mmHg)
Standard 1289/11 3339/159* 3499/145* 2549/70* 2559/141* 2169/91* 1849/38 1729/32 1549/40
HHS 1529/20 3589/157$ 3979/175$ 4289/96$ 3449/82$ 2089/57 1759/34 1849/50 1659/47
TPA 1509/10 3219/1891§ 3489/1481§ 3969/1791§ 2989/451§ 2489/261§ 2499/271§ 2489/461§ 2009/29
Glucose (mg/dl)
Standard 1289/16& 3219/33*,& 4169/40*,& 2979/43*,& 2319/46*,& 1799/27*,& 2229/83*,& 1729/58 1389/25
HHS 1509/30 2999/65$, 3729/84$, 3199/89$, 2389/49$, 2249/70$, 2069/61$, 1839/56 1479/47
TPA 979/14 1459/711§ 1529/441§ 1549/46 1039/10 899/11 979/31 1299/49 1499/731§
Data are means9/S.D. (n/4 in each group).
* pB/0.05 standard vs. baseline.
$ pB/0.05 HHS vs. baseline.
§ pB/0.05 TPA vs. baseline;
& pB/0.05 standard vs. TPA.

/ pB/0.05 HHS vs. TPA.
Fig. 2. PWI signal intensity in% of pre-ischaemic baseline 20 min after
ROSC. The initial post-ischaemic cerebral recirculation was signifi-
cantly higher after CPR in combination with application of an
hypertonic/hyperoncotic solution than after standard resuscitation or
CPR in combination with systemic fibrinolysis (TPA). Data are
means9/SEM and expressed in % of baseline. /, pB/0.05 HHS vs.
TPA; #, pB/0.05 HHS vs. standard.
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whereas CBF had already returned to baseline in the
TPA and in the standard group (pB/0.05; Fig. 3). The
drop of the signal intensities below the pre-ischaemic
level approximately 80 min after ROSC indicated the
onset of the delayed hypoperfusion. At 100/120 min
after ROSC, the signals decreased in all groups in both
anatomical regions in parallel to 45/50% of their
baseline intensities (pB/0.05). Osmotic or fibrinolytic
Fig. 3. Time courses of the regional PWI signal intensity in the cortex (a) and in the basal ganglia (b) before and after resuscitation from 15 to 20 min
CA. Standard/CPR according to AHA guidelines [20]; HHS/CPR in combination with hypertonic/hyperoncotic treatment; TPA/CPR in
combination with systemic fibrinolysis; n/4 in each group. Data are means9/S.E.M. and expressed in % of baseline. During CA, no PWI
measurements were performed. *, pB/0.05 standard vs. pre-ischaemic baseline; 8, pB/0.05 HHS vs. baseline; §, pB/0.05 TPA vs baseline;/, pB/0.05
HHS vs. TPA; #, pB/0.05 HHS vs. standard.
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did not reverse hypoperfusion, but the time course
differed in cortex and basal ganglia, depending on the
kind of therapeutic intervention. In TPA treated cats a
significant reduction of the PWI signal intensity in
comparison to the prearrest level persisted in both
anatomical regions until the end of the observation
period (pB/0.05). In the cortex of standard and HHS
treated animals a significant difference of the PWI
intensity compared with the pre-ischaemic signal was
not longer present during the last hour of evaluation,
and this trend was also apparent in the basal ganglia of
the standard group but not of the HHS group.
3.3. Diffusion-weighted imaging
Fig. 1 shows quantitative coronal ADC maps before,
during, and 6 h after 20 min CA. In the cerebral cortex,
ADC returned close to control, irrespective of treatment
(Table 2). In the basal ganglia, in contrast, ADC
recovered only in cats that received HHS or TPA, but
not in animals resuscitated with the standard protocol.
However, this difference between the treatment groups
was not statistically significant.
3.4. 1H-spectroscopy
In Fig. 4 in vivo 1H-MR spectra of a localized volume
in the cortex before and during 20 min CA, and 6 h after
successful cardiac resuscitation are demonstrated. Dur-
ing CA the (lactate/lipid)/(Cr/PCr)-ratio increased in
the cortex and the basal ganglia to an almost similar
level in all groups, although the spectra were acquired
later in the basal ganglia (10 min after induction of CA)
than in the cortex (5 min after induction of CA) (Table
3). This finding demonstrates that most of the lactate
derived from anaerobic glycolysis is generated within 5
min after the induction of CA, and that the calculated
lactate ratio levels off at 1.59/1.75 in the cortex and at
1.67/1.77 in the basal ganglia (Table 3).
After reperfusion, the time course of this ratio differed
between the two brain regions and between the different
treatment groups. In the basal ganglia of HHS and
standard treated animals the lactate-ratio reached its
maximum during CA and slowly declined during
recirculation to a level approximately 40% above base-
line (n.s.). In the basal ganglia of the TPA group the
lactate ratio further increased after initial recirculation
and only gradually returned to a level which was
approximately twice the resting value (pB/.05 vs. base-
line and vs. HHS and standard). In the cortex the lactate
ratio rose in all animals during the period of initial
hyperperfusion, irrespective of treatment, and fell shar-
ply after reaching its maximum 20 min after ROSC
(Table 3). Once this initial sharp decline occured, the
lactate-ratio continued to decrease in all groups but to a
lower level in HHS and standard treated animals than in
TPA treated cats. In the latter group the lactate ratio
remained on a higher level both in the cortex and in the
basal ganglia in comparison to the pre-ischaemic level
(pB/0.05) and to the HHS treated group (pB/0.05) until
the end of the observation period.
Fig. 4. In vivo 1H-MR spectra of a localized volume in the cortex
before and during 20 min CA, and after 6 h recirculation. Spectra were
acquired from an animal receiving a bolus injection of 1 mg/kg TPA
during CPR. Note the increase of lactate during global ischemia. With
longer recirculation times lactate gradually returned to near baseline.
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3.5. Bioluminescence imaging of tissue metabolites and
fluorescence imaging of pH
The bioluminescence lactate measurements revealed
regional tissue contents that were in agreement with the
results from the 1H-MRS measurements of the
(lactate/lipid)/(Cr/PCr)-ratio. The lactate content
after 6 h recirculation was slightly higher in basal
ganglia than in the cortex in all groups (n.s.), and in
TPA treated animals in comparison to the HHS group
(pB/0.05; Table 4). Tissue acidity and ATP depletion
were almost identical in animals resuscitated with the
different resuscitation protocols. Only the glucose con-
tent in basal ganglia of HHS treated animals was higher
compared with the other groups (pB/0.05 vs. TPA and
standard; Table 4).
4. Discussion
This is the first study demonstrating the precise time
course of cerebral reperfusion after global cerebral
ischaemia in cats with the use of arterial spin tagging
PWI. The spin tagging method has been shown to be
sensitive to fast perfusion changes in rat brain occuring
after functional activation of cerebral cortex [8] or
during hypercapnia [9]. In the present study, the
feasibility of serial measurements of regional cerebral
perfusion with arterial spin labeling was demonstrated
in a feline model of prolonged CA and CPR. During
post-CA resuscitation, variations of regional CBF that
are consistent with the previously documented change
from hyper- to hypoperfusion [6] were reliably mon-
itored both in the cortex and in the basal ganglia. The
combination of arterial spin tagging PWI with DWI and
localized 1H-MRS permitted simultaneous monitoring
of regional cerebral perfusion and metabolic recovery.
With this setup, a new technical approach to perform
longitudinal studies of the relationship between cerebral
recirculation dynamics and metabolic recovery after
global and focal cerebral ischaemia has become avail-
able. Furthermore, the combination of MR imaging and
spectroscopic techniques facilitates the evaluation of
therapeutical approaches on brain reperfusion and
metabolic recovery after cerebral ischaemia in experi-
mental and clinical conditions. Combinations of MR
techniques have been repeatedly employed to describe
the temporal relationship between ADC and CBF
measurements in stroke patients [31/39]. In these
investigations evidence was provided that ischaemic
brain lesions with severe CBF reductions were asso-
ciated with lower ADC values [31/39]. Thijs et al.
reported an association of low ADC/CBF measurements
with higher NIH stroke scale scores [32]; Marks et al.
[34] and Kidwell et al. [35] documented amelioration of
early brain reperfusion and recanalization of obstructed
cerebral vessels after acute stroke and i.v. or intra-
arterial thrombolysis with a recombinant tissue plasmi-
nogen activator (rt-PA). In contrast to the great number
of clinical studies employing MRI techniques for the
evaluation of cerebral reperfusion and recovery after
stroke, DWI has only rarely [38,39] and PWI has never
been used to monitor brain resuscitation in post-CA
patients. In comatose survivors of cardiac resuscitation
DWI revealed severe anoxic-ischaemic brain injury, and
extensive abnormalities indicated little to no prospects
for functional cerebral recovery [38]. Diffuse abnormal-
ities were also observed in basal ganglia, cerebellum,
cortex, and white matter of patients resuscitated from
prolonged CA (/8 min) [39]. DWI therefore seems to
be helpful for evaluating cerebral post-ischaemic injury,
and to determine the prognosis and management of
these patients.
Based on these findings we tried to establish whether
application of either a hypertonic/hyperoncotic solution
or a plasminogen-activator during CPR was superior for
Table 2
Apparent diffusion coefficient (ADC) after standard CPR or resuscitation in combination with HHS or TPA
Prearrest Recirculation (min after ROSC)
40 60 120 180 240 300 360
Cortex
Standard 100 989/5 989/3 969/6 979/4 979/6 959/6 979/5
HHS 100 1029/10 1009/8 1009/7 999/7 969/7 999/8 1019/6
TPA 100 979/12 979/13 949/12 959/12 989/10 999/11 979/10
Basal ganglia
Standard 100 949/9 939/11 939/14 919/11* 919/9* 929/10* 929/10*
HHS 100 999/9 999/7 959/11 949/13 959/9 969/8 979/12
TPA 100 999/12 979/14 969/9 969/8 969/12 969/10 979/9
Data are means9/S.D. (n/4 in each group) and presented in % of mean pre-ischaemic value.
* pB/0.05 standard vs. baseline.
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circulatory and metabolic brain recovery in comparison
to standard life support [20]. We could demonstrate that
initial cerebral recirculation was improved after hyper-
tonic/hyperoncotic treatment but not after systemic
thrombolysis. These observations are consistent only
in part with previously published studies in which both
therapeutic regimes reduced significantly cerebral no-
reflow after CA [21,22]. Nozari et al. demonstrated a
beneficial effect of a hypertonic saline/dextrane solu-
tion on CBF during CPR in combination with contin-
uous intra-aortic balloon occlusion (IABO) in piglets
[40]. However, when the hypertonic solution was applied
without performing IABO, CBF did not improve [40].
Moreover, the treatment with the hypertonic solution
did not ameliorate post-resuscitation cerebral hypoper-
fusion as confirmed by the present investigation. Sys-
temic fibrinolysis also failed to prevent post-ischaemic
hypoperfusion and made even worse metabolic recovery
as indicated by an extended preservation of the anaero-
bic metabolism in the 1H-MRS measurements of the
lactate-ratio and the bioluminescence images. However,
the lack of amelioration of cerebral hypoperfusion with
either osmotic or fibrinolytic therapy was not surprising
since the pathophysiology of cerebral no-reflow and
delayed hypoperfusion differs fundamentally [41]. The
pathophysiology of no-reflow is multifactorial and
includes vascular factors like obstruction of the capillary
lumen by endothelial flaps [42] or compression by
swollen perivascular glial cells [43], blood factors like
viscosity changes [44], sludging of erythrocytes [45], the
formation of platelet aggregates [46] or an imbalance of
blood coagulation [47], and general cardiovascular
factors like post-ischaemic hypotension [48]. In contrast,
the protracted hypoperfusion after global cerebral
ischaemia is a functional disturbance due to an increased
vasotonus [41]. Reduction of the vascular tone with
various vasodilating drugs [3,48] yielded minor improve-
ment of hypoperfusion, the most promising results were
achieved with selective antagonists of the endothelin
type A receptor [18,49,50]. The latter approach even
improved neurological outcome after CA in Mongolian
gerbils [50] and rats [19], suggesting that delayed
hypoperfusion is not only an epiphenomenon of post-
ischaemic metabolic disturbances but could be a sepa-
rate pathogenic factor of cerebral recovery. However, a
difference between the severity of post-ischaemic hypo-
perfusion between animals resuscitated in combination
with thrombolytic therapy in comparison to the other
two groups, standard CPR according to AHA guidelines
[20] or in combination with the hypertonic/hyperoncotic
solution, was not detectable and, therefore, does not
explain the preservation of higher cerebral lactate in the
first group. The observation of higher cerebral lactate
stands also in contrast to the complete recovery of the
Table 3
(Lactate9/lipid)/(creatin/phosphocreatine)-ratio after standard CPR or resuscitation in combination with HHS or TPA
Prearrest During CA Recirculation (min after ROSC)
20 40 60 120 180 240 300 360
Cortex
Standard 0.439/0.09 1.759/0.36* 2.369/0.36* 1.349/0.33* 0.889/0.19* 0.959/0.17* 0.879/0.16* 0.739/0.10* 0.759/0.14* 0.739/0.18*
HHS 0.489/0.14 1.709/0.39$ 2.379/0.47$ 1.329/0.21$ 0.849/0.19$ 0.729/0.35 0.869/0.17$ 0.719/0.14 0.679/0.13 0.619/0.12
TPA 0.449/0.07 1.599/0.34§ 2.279/0.54§ 1.849/0.33§,&, 1.179/0.29§,&, 1.049/0.47§, 1.219/0.46§,&, 0.879/0.18§ 0.869/0.10§ 0.869/0.12§,
Basal ganglia
Standard 0.579/0.05 1.719/0.26* 1.729/0.43* 1.419/0.33* 1.299/0.39* 0.929/0.07 0.989/0.19* 1.059/0.28* 0.879/0.14 0.829/0.28
HHS 0.549/0.08 1.769/0.25$ 1.639/0.32$ 1.349/0.31$ 1.269/0.35$ 0.929/0.27 0.849/0.26 0.819/0.30 0.829/0.24 0.839/0.18
TPA 0.599/0.05 1.679/0.30§ 1.789/0.21§ 1.639/0.43§, 1.349/0.19§ 1.199/0.17§ 1.229/0.36§, 1.229/0.24§, 1.199/0.22§,&, 1.139/0.08§,&,
Data are means9/S.D. (n/4 in each group).
* pB/0.05 standard vs. baseline.
$ pB/0.05 HHS vs. baseline.
§ pB/0.05 TPA vs. baseline.
& pB/0.05 standard vs. TPA.

/ pB/0.05 HHS vs. TPA.
Table 4
Quantitative bioluminescent and fluorescent measurements
Standard HHS TPA
Cortex
Lactate (mmol/g) 4.319/2.75 3.979/1.31 4.619/1.54
pH 7.169/0.16 7.199/0.18 7.099/0.25
ATP (mmol/g) 2.669/0.41 2.769/0.89 2.529/0.64
Glucose (mmol/g) 6.379/1.08 6.889/2.90 6.179/1.28
Basal ganglia
Lactate (mmol/g) 4.379/1.79 4.159/1.90 4.919/1.72
pH 7.159/0.14 7.149/0.17 7.089/0.21
ATP (mmol/g) 2.449/0.73 2.669/0.38 2.449/0.62
Glucose (mmol/g) 6.409/1.76 7.749/2.59,# 6.669/2.48
Data are means9/S.D. (n/4 in each group); ATP, adenosine
triphosphate.

/ pB/0.05 HHS vs. TPA.
# pB/0.05 standard vs. HHS.
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ADC in diffusion-weighted images indicating restora-
tion of cerebral water and ion homeostasis in the TPA
treated animals. Because no differences of systemic
factors like duration of CPR, adrenaline dosage during
CPR, haemodynamic or systemic metabolic recovery
after restoration of circulation was present between the
experimental groups, we cannot provide a good expla-
nation for the higher cerebral lactate after TPA treat-
ment. Since the present investigation was the first study
in which the effects of thrombolysis during CPR on
cerebral metabolic recovery were assessed, this observa-
tion has to await confirmation. The higher cerebral
lactate clearly stands in contrast to our previous
experimental documentation of an improved reflow
[22] and to a clinical study describing the successful
use of TPA during CPR with higher hospital discharge
and good neurological outcome [51].
Two important limitations of the present investigation
have to be discussed. Despite statistically significant
differences between the experimental groups in various
variables, it has to be considered that only four animals
were included in each experimental group. Therefore,
the conclusions drawn from the results lack of statistical
power. This has to be considered in the discussion of the
observation of higher cerebral lactate after CPR in
combination with TPA treatment. One animal in this
group recovered poorly throughout the observation
period after resuscitation from 20 min CA. Finally, it
has to be mentioned that, originally, CA was induced
for 25 min in six additional animals. Only three animals
after 25 min CA were successfully resuscitated, both
animals from the TPA group and one animal from the
HHS group. Because no animal from the standard
group was successfully resuscitated a comparison of
the variables between the experimental groups was not
possible and, therefore, the data of these animals were
not presented.
In conclusion, the present investigation demonstrates
that the combination of arterial spin-tagging PWI with
DWI and localized 1H-MRS enables to perform long-
itudinal studies of the relationship between cerebral
recirculation dynamics and metabolic recovery after
global cerebral ischaemia. With this set-up, it was
demonstrated that initial cerebral recirculation was
improved after hypertonic-hyperosmotic treatment.
Moreover, osmotic and thrombolytic therapy were
ineffective in preventing or ameliorating post-ischaemic
delayed hypoperfusion. Whether the two therapeutic
regimens are superior for long-term brain recovery
compared with the standard protocol in clinical use
depends on the pathophysiological importance of post-
ischaemic hypoperfusion. As long as this disturbance is
not reversed, the improvements presented here will only
be the first step towards a more efficient haemodynamic
therapy of post-ischaemic brain resuscitation.
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